Literature DB >> 33550560

Global metabolomic profiling reveals hepatic biosignatures that reflect the unique metabolic needs of late-term mother and fetus.

Nipun Saini1, Manjot Virdee1, Kaylee K Helfrich1,2, Sze Ting Cecilia Kwan1, Susan M Smith3,4.   

Abstract

OBJECTIVE: Gestational disorders including preeclampsia, growth restriction and diabetes are characterized, in part, by altered metabolic interactions between mother and fetus. Understanding their functional relevance requires metabolic characterization under normotypic conditions.
METHODS: We performed untargeted metabolomics on livers of pregnant, late-term C57Bl/6J mice (N = 9 dams) and their fetuses (pooling 4 fetuses/litter), using UPLC-MS/MS.
RESULTS: Multivariate analysis of 730 hepatic metabolites revealed that maternal and fetal metabolite profiles were highly compartmentalized, and were significantly more similar within fetuses (ρaverage = 0.81), or within dams (ρaverage = 0.79), than within each maternal-fetal dyad (ρaverage = - 0.76), suggesting that fetal hepatic metabolism is under distinct and equally tight metabolic control compared with its respective dam. The metabolite profiles were consistent with known differences in maternal-fetal metabolism. The reduced fetal glucose reflected its limited capacity for gluconeogenesis and dependence upon maternal plasma glucose pools. The fetal decreases in essential amino acids and elevations in their alpha-keto acid carnitine conjugates reflects their importance as secondary fuel sources to meet fetal energy demands. Whereas, contrasting elevations in fetal serine, glycine, aspartate, and glutamate reflects their contributions to endogenous nucleotide synthesis and fetal growth. Finally, the elevated maternal hepatic lipids and glycerol were consistent with a catabolic state that spares glucose to meet competing maternal-fetal energy demands.
CONCLUSIONS: The metabolite profile of the late-term mouse dam and fetus is consistent with prior, non-rodent analyses utilizing plasma and urine. These data position mouse as a suitable model for mechanistic investigation into how maternal-fetal metabolism adapts (or not) to gestational stressors.

Entities:  

Keywords:  Amino acids; Gestational stress; Hepatic; Nucleotides; Pregnancy; Untargeted metabolomics

Mesh:

Substances:

Year:  2021        PMID: 33550560      PMCID: PMC8543356          DOI: 10.1007/s11306-021-01773-8

Source DB:  PubMed          Journal:  Metabolomics        ISSN: 1573-3882            Impact factor:   4.290


  61 in total

Review 1.  Fetal metabolism and fetal growth.

Authors:  C T Jones
Journal:  J Reprod Fertil       Date:  1976-05

Review 2.  The future perspective: metabolomics in laboratory medicine for inborn errors of metabolism.

Authors:  Yana Sandlers
Journal:  Transl Res       Date:  2017-06-15       Impact factor: 7.012

3.  AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet.

Authors:  P G Reeves; F H Nielsen; G C Fahey
Journal:  J Nutr       Date:  1993-11       Impact factor: 4.798

4.  Applications of Metabolomics in the Study and Management of Preeclampsia; A Review of the Literature.

Authors:  Rachel S Kelly; Rachel T Giorgio; Bo L Chawes; Natalia I Palacios; Kathryn J Gray; Hoooman Mirzakhani; Ann Wu; Kevin Blighe; Scott T Weiss; Jessica Lasky-Su
Journal:  Metabolomics       Date:  2017-06-12       Impact factor: 4.290

5.  Glutathione S-transferases and thiol concentrations in embryonic and early fetal tissues.

Authors:  M T Raijmakers; E A Steegers; W H Peters
Journal:  Hum Reprod       Date:  2001-11       Impact factor: 6.918

6.  Ribonucleic acid nucleotides in maternal and fetal tissues derive almost exclusively from synthesis de novo in pregnant mice.

Authors:  J J Boza; F Jahoor; P J Reeds
Journal:  J Nutr       Date:  1996-07       Impact factor: 4.798

7.  Longitudinal Metabolomic Profiling of Amino Acids and Lipids across Healthy Pregnancy.

Authors:  Karen L Lindsay; Christian Hellmuth; Olaf Uhl; Claudia Buss; Pathik D Wadhwa; Berthold Koletzko; Sonja Entringer
Journal:  PLoS One       Date:  2015-12-30       Impact factor: 3.240

8.  Newborn screening for haemophilia: The views of families and adults living with haemophilia in the UK.

Authors:  Felicity K Boardman; Rachel Hale; Philip J Young
Journal:  Haemophilia       Date:  2019-02-28       Impact factor: 4.287

9.  Examining the predictive accuracy of metabolomics for small-for-gestational-age babies: a systematic review.

Authors:  Debora Farias Batista Leite; Aude-Claire Morillon; Elias F Melo Júnior; Renato T Souza; Fergus P McCarthy; Ali Khashan; Philip Baker; Louise C Kenny; Jose Guilherme Cecatti
Journal:  BMJ Open       Date:  2019-08-10       Impact factor: 2.692

10.  Metabolomics of Human Amniotic Fluid and Maternal Plasma during Normal Pregnancy.

Authors:  Magdalena Orczyk-Pawilowicz; Ewa Jawien; Stanislaw Deja; Lidia Hirnle; Adam Zabek; Piotr Mlynarz
Journal:  PLoS One       Date:  2016-04-12       Impact factor: 3.240

View more
  1 in total

1.  Untargeted Metabolome Analysis Reveals Reductions in Maternal Hepatic Glucose and Amino Acid Content That Correlate with Fetal Organ Weights in a Mouse Model of Fetal Alcohol Spectrum Disorders.

Authors:  Nipun Saini; Manjot S Virdee; Kaylee K Helfrich; Sze Ting Cecilia Kwan; Sandra M Mooney; Susan M Smith
Journal:  Nutrients       Date:  2022-03-05       Impact factor: 6.706

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.